Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.41) by 4.88 percent. This is a 34.48 percent decrease over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $16.30 million which beat the analyst consensus estimate of $15.46 million by 5.43 percent. This is a 14.76 percent increase over sales of $14.20 million the same period last year.
JP Morgan Downgrades Ciena to Neutral, Lowers Price Target to $45
JP Morgan analyst Samik Chatterjee downgrades Ciena (NYSE:CIEN) from Overweight to Neutral and lowers the price target from $62 to $45.
